LONDON--Drugs that combat obesity could for the first time be included on the World Health Organization’s “essential medicines list,” used to guide government purchasing decisions in low ...
This page features an assortment of drug(s) that could potentially trigger 'Central obesity' as a Side-effect or adverse response. It is not uncommon for medications to have some tolerable mild ...
Dr. Carroll is the chief health officer of Indiana University and writes often on health policy. We like to think we understand the drugs we take, especially after rigorous trials have proved ...
Almost 1,900 doctors signed up to take this year's exam to become certified in treating obesity, according to the American ...
We’ll send you a myFT Daily Digest email rounding up the latest The FT View news every morning. It is somewhat ironic that Denmark’s economic growth in the first half of the year was driven ...
Pharma giants Novo Nordisk and Eli Lilly might’ve led the way into a new era of obesity drugs, but they’re not going to own it, biotech executives say. “We’re really just at the ...
Ozempic commercials are, at this point, ubiquitous and while that’s an anecdotal example, it also represents confirmation that obesity drugs are the next big thing in the pharmaceuticals industry.
A host of technical, institutional and economic issues pose grave challenges to the development and deployment of safe and effective anti-obesity medications. The morbidity and mortality risks ...
Obesity drugs are dead following FDA's rejection of Orexigen Tuesday, which also spells doom for Vivus and Arena Pharma. Obesity drugs are dead following FDA's rejection of Orexigen Tuesday, which ...
Drug company Arena Pharmaceuticals is under pressure to produce stellar results from a phase III study of its obesity drug later this month. carries a heavy burden. Not only is the San Diego-based ...
Share on Facebook. Opens in a new tab or window Share on Twitter. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In this video, Harlan Krumholz, MD, SM, of the Yale ...
The popularity of Ozempic for weight loss has fueled a cottage industry selling off-brand versions, taking advantage of a regulation allowing pharmacies to copy drugs in shortage.
